Cell & Gene Therapies: US FDA Broadens Acceptable Use of RWD, Registries and AI

 
• By Manas Mishra
  
US FDA encourages the use of digital health tools in new guidance to sponsors of CGT trials. (Shutterstock)

More from Cell & Gene Therapies

More from Advanced Technologies